Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Russo Spena, Concetta"'
Autor:
Russo Spena, Concetta, De Stefano, Lucia, Palazzolo, Stefano, Salis, Barbara, Granchi, Carlotta, Minutolo, Filippo, Tuccinardi, Tiziano, Fratamico, Roberto, Crotti, Sara, D'Aronco, Sara, Agostini, Marco, Corona, Giuseppe, Caligiuri, Isabella, Canzonieri, Vincenzo, Rizzolio, Flavio
Publikováno v:
In Journal of Controlled Release 10 July 2018 281:1-10
Autor:
Farra, Rossella, Musiani, Francesco, Perrone, Francesca, Čemažar, Maja, Kamenšek, Urška, Tonon, Federica, Abrami, Michela, Ručigaj, Aleš, Grassi, Mario, Pozzato, Gabriele, Bonazza, Deborah, Zanconati, Fabrizio, Forte, Giancarlo, El Boustani, Maguie, Scarabel, Lucia, Garziera, Marica, Russo Spena, Concetta, De Stefano, Lucia, Salis, Barbara, Toffoli, Giuseppe, Rizzolio, Flavio, Grassi, Gabriele, Dapas, Barbara
Publikováno v:
Molecules, vol. 23, no. 4, 777, 2018.
Despite the advances in anticancer therapies, their effectiveness for many human tumors is still far from being optimal. Significant improvements in treatment efficacy can come from the enhancement of drug specificity. This goal may be achieved by co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3505::2b49b88393693753f2054c96bf46172f
https://repozitorij.uni-lj.si/IzpisGradiva.php?id=131823
https://repozitorij.uni-lj.si/IzpisGradiva.php?id=131823
Autor:
RUSSO SPENA, Concetta
I focused my attention on Pin1 expression and chemical inhibition in HGS-EOC models. First, I confirmed that Pin1 is effectively involved in tumor progression utilizing mouse ovarian surface epithelial cancer cell line (STOSE), which closely recapitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c4358129b23c2f81bf0f01d561973f06
https://hdl.handle.net/11368/2957167
https://hdl.handle.net/11368/2957167
Autor:
Kumar, Vinit, Hadla, Mohamad, Caligiuri, Isabella, Russo Spena, Concetta, Kempter, Susanne, Corona, Giuseppe, Toffoli, Giuseppe, Rizzolio, Flavio, BAYDA, SAMER, PALAZZOLO, STEFANO
In cancer therapy, it is imperative to increase the efficacy and reduce side effects of chemotherapeutic drugs. Nanotechnology offers the unique opportunity to overcome these barriers. In particular, in the last few years, DNA nanostructures have gai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b53f39cb403fc18417d8e7db01564d92
http://hdl.handle.net/11368/2851691
http://hdl.handle.net/11368/2851691
Autor:
Russo Spena, Concetta, De Stefano, Lucia, Poli, Giulio, Granchi, Carlotta, El Boustani, Maguie, Ecca, Fabrizio, Grassi, Gabriele, Grassi, Mario, Canzonieri, Vincenzo, Giordano, Antonio, Tuccinardi, Tiziano, Caligiuri, Isabella, Rizzolio, Flavio
Publikováno v:
Journal of Cellular Physiology; Sep2019, Vol. 234 Issue 9, p15708-15716, 9p
Autor:
Scarabel, Lucia, Perrone, Francesca, Garziera, Marica, Farra, Rossella, Grassi, Mario, Musiani, Francesco, Russo Spena, Concetta, Salis, Barbara, De Stefano, Lucia, Toffoli, Giuseppe, Rizzolio, Flavio, Tonon, Federica, Abrami, Michela, Chiarappa, Gianluca, Pozzato, Gabriele, Forte, Giancarlo, Grassi, Gabriele, Dapas, Barbara
Publikováno v:
Expert Opinion on Drug Delivery; June 2017, Vol. 14 Issue: 6 p797-810, 14p
Autor:
Farra, Rossella, Musiani, Francesco, Perrone, Francesca, Čemažar, Maja, Kamenšek, Urška, Tonon, Federica, Abrami, Michela, Ručigaj, Aleš, Grassi, Mario, Pozzato, Gabriele, Bonazza, Deborah, Zanconati, Fabrizio, Forte, Giancarlo, El Boustani, Maguie, Scarabel, Lucia, Garziera, Marica, Russo Spena, Concetta, De Stefano, Lucia, Salis, Barbara, Toffoli, Giuseppe
Publikováno v:
Molecules; Apr2018, Vol. 23 Issue 4, p777, 1p, 5 Diagrams, 3 Charts, 1 Graph
Autor:
Gianluca Chiarappa, Francesca Perrone, Barbara Salis, Gabriele Grassi, Giancarlo Forte, Gabriele Pozzato, Concetta Russo Spena, Giuseppe Toffoli, Lucia De Stefano, Marica Garziera, Flavio Rizzolio, Francesco Musiani, Michela Abrami, Rossella Farra, Federica Tonon, Mario Grassi, Lucia Scarabel, Barbara Dapas
Introduction: hepatocellular carcinoma (hcc) is the predominant form of primary liver cancer and the second leading cause of cancer-associated mortality worldwide. available therapies for hcc have limited efficacy due to often late diagnosis and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27d5f7439fa7432e33dc96e1baa41fd
http://hdl.handle.net/11368/2903520
http://hdl.handle.net/11368/2903520
Autor:
Filippo Minutolo, Concetta Russo Spena, Sara Crotti, Tiziano Tuccinardi, Isabella Caligiuri, Giuseppe Corona, Roberto Fratamico, Flavio Rizzolio, Lucia De Stefano, Marco Agostini, Vincenzo Canzonieri, Sara D'Aronco, Stefano Palazzolo, Barbara Salis, Carlotta Granchi
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 281
Pin1, a prolyl isomerase that sustains tumor progression, is overexpressed in different types of malignancies. Functional inactivation of Pin1 restrains tumor growth and leaves normal cells unaffected making it an ideal pharmaceutical target. Althoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20d87532a8e808f82ac1437e8a7752d5
https://pubmed.ncbi.nlm.nih.gov/29746956
https://pubmed.ncbi.nlm.nih.gov/29746956
Autor:
Palazzolo S; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy.; Clinical and Experimental Pharmacology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Hadla M; Clinical and Experimental Pharmacology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Russo Spena C; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Caligiuri I; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Rotondo R; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Adeel M; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy.; Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Venice 30172, Italy., Kumar V; Clinical and Experimental Pharmacology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy.; Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Noida 201313, India., Corona G; Immunopathology and Cancer Biomarkers unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Canzonieri V; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy.; Department of Medical, Surgical and Health Science, University of Trieste, Trieste 34137, Italy., Toffoli G; Clinical and Experimental Pharmacology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Rizzolio F; Pathology unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy.; Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Venice 30172, Italy.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Dec 12; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 12.